Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-129,780
Closed -$8.46M 97
2025
Q4
$8.46M Buy
+129,780
New +$10.4M 0.75% 46
2024
Q3
Sell
-4,800
Closed -$265K 133
2024
Q2
$265K Buy
+4,800
New +$261K 0.03% 116
2023
Q4
Sell
-102,762
Closed -$3.69M 193
2023
Q3
$3.69M Sell
102,762
-3,100
-3% -$107K 0.4% 68
2023
Q2
$3.35M Sell
105,862
-91,616
-46% -$3.5M 0.34% 86
2023
Q1
$6.08M Sell
197,478
-39,500
-17% -$1.2M 0.66% 51
2022
Q4
$7.34M Sell
236,978
-516,855
-69% -$11.9M 0.74% 48
2022
Q3
$14.1M Sell
753,833
-411,700
-35% -$7.88M 1.51% 18
2022
Q2
$21M Sell
1,165,533
-44,343
-4% -$572K 2.6% 14
2022
Q1
$16.6M Buy
+1,209,876
New +$20.2M 1.26% 31

Other funds holding ACLX

Clough Capital Partners's ACLX Position: Q1 2026 in Review

Clough Capital Partners sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 129,780 shares — an estimated $8.46M sold.

Clough Capital Partners first reported a position in ACLX in Q1 2022 and held it in 9 quarters. The position peaked at $21M in Q2 2022. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Clough Capital Partners reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • Clough Capital Partners sold 129,780 Arcellx shares in Q1 2026, an estimated $8.46M.
  • Clough Capital Partners first reported a position in Arcellx in Q1 2022 and held it in 9 quarters.
  • Clough Capital Partners's Arcellx position peaked at $21M in Q2 2022.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Clough Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.